Trial · NCT03088137
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Oocytes (Intention-to-Treat, ITT) | Primapur (Follitropin Alfa) | 12.16 | Standard Deviation 7.28 | Number of retrieved oocytes | |
| Oocytes (Intention-to-Treat, ITT) | Gonal-f (Follitropin Alfa) | 11.62 | Standard Deviation 6.29 | Number of retrieved oocytes | |
| Number of Follicles With Size ≥ 16 mm | Primapur (Follitropin Alfa) | 12.09 | Standard Deviation 6.159 | Number of follicles | |
| Number of Follicles With Size ≥ 16 mm | Gonal-f (Follitropin Alfa) | 11.38 | Standard Deviation 4.965 | Number of follicles | |
| Mature Oocytes | Primapur (Follitropin Alfa) | 9.64 | Standard Deviation 6.270 | Number of mature oocytes (MII stage) | |
| Mature Oocytes | Gonal-f (Follitropin Alfa) | 9.86 | Standard Deviation 5.546 | Number of mature oocytes (MII stage) | |
| Fertilised Oocytes | Primapur (Follitropin Alfa) | 8.127 | Standard Deviation 6.608 | Number of oocytes with 2PN | |
| Fertilised Oocytes | Gonal-f (Follitropin Alfa) | 8.764 | Standard Deviation 5.850 | Number of oocytes with 2PN | |
| Percentage of Patients With Embryo Transfer | Primapur (Follitropin Alfa) | Embryo transfer on day 3 (%) | 11 | Participants | |
| Percentage of Patients With Embryo Transfer | Gonal-f (Follitropin Alfa) | Embryo transfer on day 3 (%) | 9 | Participants | |
| Percentage of Patients With Embryo Transfer | Primapur (Follitropin Alfa) | Embryo transfer on day 5 (%) | 38 | Participants | |
| Percentage of Patients With Embryo Transfer | Gonal-f (Follitropin Alfa) | Embryo transfer on day 5 (%) | 40 | Participants | |
| Total Dose of Follitropin Alfa | Primapur (Follitropin Alfa) | 1532.7 | Standard Deviation 267.2 | Total dose (IU) | |
| Total Dose of Follitropin Alfa | Gonal-f (Follitropin Alfa) | 1517.9 | Standard Deviation 255.2 | Total dose (IU) | |
| Number of Days of Follitropin Alfa Treatment | Primapur (Follitropin Alfa) | 9.745 | Standard Deviation 1.075 | Days | |
| Number of Days of Follitropin Alfa Treatment | Gonal-f (Follitropin Alfa) | 9.727 | Standard Deviation 1.027 | Days | |
| Number of Patients With Follitropin Alfa Dose Correction | Primapur (Follitropin Alfa) | 13 | Participants | ||
| Number of Patients With Follitropin Alfa Dose Correction | Gonal-f (Follitropin Alfa) | 11 | Participants | ||
| Number of Patients With Cycle Cancellation | Primapur (Follitropin Alfa) | 0 | Participants | ||
| Number of Patients With Cycle Cancellation | Gonal-f (Follitropin Alfa) | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03088137/results